Results 141 to 150 of about 3,032,107 (315)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

open access: diamond, 2018
Kumar Prabhash   +14 more
openalex   +1 more source

Author response for "Impact of oral lesions on the quality of life of psoriatic individuals: a case‐control study"

open access: gold, 2020
Amanda Almeida Costa   +5 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Promoting structural sustainable design through the influence of quality control assessments. [PDF]

open access: yesSci Rep
Lux T   +5 more
europepmc   +1 more source

Heart Failure and Protein Quality Control [PDF]

open access: bronze, 2006
Xuejun Wang, Jeffrey Robbins
openalex   +1 more source

Home - About - Disclaimer - Privacy